Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03170154 · ClinicalTrials.gov registry record · NA

Clinical Investigation of the Clareon® Intraocular Lens (IOL)

A NA study of Cataract, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
376
Enrollment target
16
Study locations

NCT03170154 is a NA study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 376 participants, above the 224-participant average among 83 other Cataract trials with a reported enrollment target (68% higher). The trial reports 16 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03170154, a NA study of Cataract, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
376 participants
Enrollment target
16
Study locations

Study Summary

The objective of this study is to compare visual acuity and adverse event outcomes from the Clareon intraocular lens (IOL) to historical safety and performance endpoint (SPE) rates.

Conditions Studied

Interventions

  • DEVICE Clareon aspheric hydrophobic acrylic monofocal IOL

Study Locations (16)

California

  • Alcon Investigative Site - Fresno
  • Alcon Investigative Site - Sacramento
  • Alcon Investigative Site - San Leandro

New York

  • Alcon Investigative Site - New York
  • Alcon Investigative Site - Poughkeepsie

North Carolina

  • Alcon Investigative Site - Elizabeth City
  • Alcon Investigative Site - Southern Pines

South Carolina

  • Alcon Investigative Site - Florence
  • Alcon Investigative Site - Ladson

Texas

  • Alcon Investigative Site - Austin
  • Alcon Investigative Site - Nacogdoches

Florida

  • Alcon Investigative Site - Deerfield Beach

Illinois

  • Alcon Investigative Site - Orland Park

Michigan

  • Alcon Investigative Site - Bloomfield Hills

Trial Details

FieldValue
Enrollment Target 376 participants
Start Date 2017-07-25
Est. Completion 2019-02-15
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT03170154

The ClinicalTrials.gov registry entry for NCT03170154 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 224-participant average among 83 other Cataract trials with a reported enrollment target (68% higher). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Clareon aspheric hydrophobic acrylic monofocal IOL is the first listed.

NCT03170154 reports 16 study locations spanning 10 distinct geographic areas - top geographies include California, New York, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03170154 about?

NCT03170154 is a clinical study titled "Clinical Investigation of the Clareon® Intraocular Lens (IOL)". The objective of this study is to compare visual acuity and adverse event outcomes from the Clareon intraocular lens (IOL) to historical safety and performance endpoint (SPE) rates.

What is the current status of trial NCT03170154?

This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2017-07-25. Estimated completion is 2019-02-15.

What conditions does trial NCT03170154 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT03170154?

The interventions under investigation include: Clareon aspheric hydrophobic acrylic monofocal IOL (DEVICE).

Who is sponsoring clinical trial NCT03170154?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03170154 being conducted?

This trial has 16 study locations across California, Florida, Illinois, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.